Work with thought leaders and academic experts in nephrology
Companies can greatly benefit from working with experts in the field of nephrology. These researchers bring a deep understanding of kidney diseases, treatments, and advancements. By collaborating with nephrology thought leaders, companies can enhance their research and development efforts, gain valuable insights into the latest trends and technologies, and accelerate innovation in the field. Whether it's developing new drugs, medical devices, or treatment protocols, partnering with nephrology experts can lead to breakthrough discoveries and improved patient outcomes.
Researchers on NotedSource with backgrounds in nephrology include Luke Connelly, Sheila Monfared, Ph.D., Kalpita R. Karan, Leo R Fitzpatrick PhD, Moji Ghadimi, Professor Esper A. Cavalheiro, Charles T. Hill, PhD, Xander van Wijk, PhD, DABCC, FADLM, Mohamad Hadla, Yasmeen George, Anil Kumar, Mehrdad Sheikhvatan, and Dr. Craig Pfeifer PhD, ATC, FHEA.
Luke Connelly
Professor of Health Economics, The University of Queensland, CBEH
Education
University of Queensland
PhD, School of Economics / June, 1999
University of Queensland
Master of Economic Studies, School of Economics / December, 1993
University of Queensland
Bachelor of Arts (Economics), School of Economics / November, 1991
Experience
The University of Bologna
Professor
The University of Queensland
Professor of Health Economics / May, 2015 — Present
Professor of Health Economics and Associate Director / January, 2008 — August, 2015
Associate Professor and Associate Director / May, 2003 — December, 2007
Queensland University of Technology
Senior Lecturer in Economics / May, 2000 — April, 2003
Lecturer / January, 1998 — April, 2000
Most Relevant Research Expertise
Other Research Expertise (42)
About
Most Relevant Publications (1+)
105 total publications
Geriatric CKD: Value-Based Nephrology
Advances in Chronic Kidney Disease / Jan 01, 2016
Yee, J. (2016). Geriatric CKD: Value-Based Nephrology. Advances in Chronic Kidney Disease, 23(1), 1–5. https://doi.org/10.1053/j.ackd.2015.11.001
See Full Profile
Sheila Monfared, Ph.D.
Specialist in Psychology, Human Factors, and Social Engineering: Delivering Impactful Research Solutions in academia and Industry
Education
Georgia Institute of Technology
Postdoctoral, Human Factors / August, 2020
Florida State University
Sports Psychology / January, 2018
Tehran University
Master of Science, Kinesiology
Experience
Saddleback College
Strategic Planning Consultant / November, 2023 — Present
● An Advisory Board Member, contributing to strategic planning at Academic Center of Excellence – Cyber Defense. ● Facilitate collaborations with academic and industry partners, relying on effective communication and skills. ● Collaborate in writing grant proposals to acquire funding for cyber competitions, and internships. ● Built a women club at the intersection of leadership and cybersecurity to fill the gender gap disparity. ● Oversee the lifecycle of students' projects from inception (topic selection) to culmination (final submission) by setting and managing expectations, tracking progress, and ensuring adherence to academic standards.
Innisghtful
Research Scientist / July, 2020 — September, 2023
● Recruited for expertise in research and collaborated with a cross-functional team of 6 engineers to validate an AI-driven wristband enhancing mental health self-awareness by Machine Learning (ML) and Natural Linguistic Processing (NLP), contributing to the product's key feature. ● Ensured project compliance with IRB, HIPAA, and FDA guidelines for 2 projects, mitigating regulatory risks and aligning with industry standards for each. ● Collaborated with the CEO and 2 other scientists to co-author a $500K grant proposal from the Small Business Innovation Research (SBIR), National Institutes of Health (NIH).
TD Bank
Senior Research Analyst / October, 2021 — December, 2022
● Worked as a Senior Design Analyst in an Agile team, driving product development of COF (card on file) from conceptualization to release, including managing project closure activities and gathering lessons learned for continuous improvement. ● Applied human factors expertise to evaluate and refine designs from a customer perspective, providing design insights to a cross-functional team of 13 experts. ● Assisted in holding a workshop with stakeholders to gather expectations translating into design requirements. ● Designed and executed complex survey using Qualtrics, to gather insights from 1800 customers for new feature implementation, aiding in informed decision-making for the Agile team.
Most Relevant Research Expertise
Other Research Expertise (12)
About
Most Relevant Publications (1+)
6 total publications
A Bio-Physio-Psychological Investigation of Athletes’ Burnout
Research Quarterly for Exercise and Sport / Feb 28, 2020
Monfared, S. S., Lebeau, J.-C., Mason, J., Cho, S. K., Basevitch, I., Perry, I., Baur, D. A., & Tenenbaum, G. (2020). A Bio-Physio-Psychological Investigation of Athletes’ Burnout. Research Quarterly for Exercise and Sport, 92(1), 189–198. https://doi.org/10.1080/02701367.2020.1715911
See Full Profile
Kalpita R. Karan
Ph.D. with a over 8 years of experience in human genetics and molecular biology. Presently, pushing pre-clinical discovery pipelines in human gene therapy at Weill Cornell Medicine.
Education
Ph.D, Human Molecular Genetics / September, 2016
Vellore Institute of Technology University
M.Sc, Biomedical Genetics / 2008
Experience
Weill Cornell Medicine
Research Associate / November, 2021 — Present
Columbia University
Postdoctoral Scientist / July, 2017 — September, 2021
Jawaharlal Nehru Centre for Advanced Scientific Research
Research Associate / July, 2016 — January, 2017
Most Relevant Research Expertise
Other Research Expertise (24)
About
Most Relevant Publications (1+)
23 total publications
Mitochondrial respiratory capacity modulates LPS-induced inflammatory signatures in human blood
Brain, Behavior, & Immunity - Health / May 01, 2020
Karan, K. R., Trumpff, C., McGill, M. A., Thomas, J. E., Sturm, G., Lauriola, V., Sloan, R. P., Rohleder, N., Kaufman, B. A., Marsland, A. L., & Picard, M. (2020). Mitochondrial respiratory capacity modulates LPS-induced inflammatory signatures in human blood. Brain, Behavior, & Immunity - Health, 5, 100080. https://doi.org/10.1016/j.bbih.2020.100080
See Full Profile
Leo R Fitzpatrick PhD
GI Pharmacology and IBD Research Consultant
Education
PhD, Physiology
Post Doctoral Fellowship, GI Physiology
Experience
California NorthState University
Penn State College of Medicine
Otsuka Pharmaceutical
Most Relevant Research Expertise
Other Research Expertise (32)
About
Most Relevant Publications (1+)
89 total publications
The Sphingosine Kinase 2 Inhibitor Opaganib Protects Against Acute Kidney Injury in Mice
International Journal of Nephrology and Renovascular Disease / Nov 01, 2022
Maines, L. W., Green, C. L., Keller, S. N., Fitzpatrick, L. R., & Smith, C. D. (2022). The Sphingosine Kinase 2 Inhibitor Opaganib Protects Against Acute Kidney Injury in Mice. International Journal of Nephrology and Renovascular Disease, Volume 15, 323–334. https://doi.org/10.2147/ijnrd.s386396
See Full Profile
Moji Ghadimi
Senior Research Fellow, University of Queensland
Education
Griffith University
PhD, Quantum Physics / January, 2017
Experience
The University of Queensland
Research Flllow level B / September, 2021 — Present
I manage a team of research assistants and PhD students who work on machine learning (in collaboration with Queensland Digital Health Centre, AU and Oxford University, UK) and quantum computing projects (in partnership with EQUS Research Centre, AU). I have published the results in world-leading level journals. - Improving quantum sensors using machine learning. - Improving training methods for quantum neural networks. - Improving the accuracy of training methods for neural networks (CNNs, LLMs) in collaboration with Griffith University, AU. - Machine Learning for detection of Kidney injury in hospitals in collaboration with Queensland Digital Health Centre. - Analysis of the ISARIC/Oxford international dataset, the largest COVID dataset in the world.
Griffith University
Research Fellow / December, 2018 — September, 2021
- Supervised stabilising quantum computers using machine learning. - Supervised the project “The Internet of the future: towards an intercontinental quantum network,” funded $870,000 to implement quantum security protocols over 60 km of optical fibre.
Ash food company
IT and Data Analytics Manager / September, 2009 — November, 2012
- Managed the IT unit of the Ash food production company, supervised 5 engineers and 15 technicians in the branches across the country and managed a total annual budget of $500,000. - Performed sales analytics with Excel and SQL Server. - I did web programming with PHP and MySQL. - I received a letter of appreciation for transforming the unit.
Most Relevant Research Expertise
Other Research Expertise (16)
About
Most Relevant Publications (1+)
19 total publications
POS-849 CHARACTERISTICS AND OUTCOMES OF HOSPITALIZED COVID-19 PATIENTS WITH ACUTE KIDNEY INJURY
Kidney International Reports / Feb 01, 2022
ESCUDERO, A. E., Ferrer, F., & Pascual, C. (2022). POS-849 CHARACTERISTICS AND OUTCOMES OF HOSPITALIZED COVID-19 PATIENTS WITH ACUTE KIDNEY INJURY. Kidney International Reports, 7(2), S366–S367. https://doi.org/10.1016/j.ekir.2022.01.887
See Full Profile
Professor Esper A. Cavalheiro
Professor Emeritus at Departamento de Neurologia e Neurocirurgia, Escola Paulista de Medicina/UNIFESP
Education
Università degli Studi di Roma La Sapienza
Post doctor
CNRS Délégation Ile-de-France Sud
Post Doc
Universidade Federal de São Paulo Departamento de Neurologia e Neurocirurgia da UNIFESP
PHD
Experience
Universidade Federal de São Paulo
Professor Emérito / February, 2019 — Present
Centro Nacional de Pesquisa em Energia e Materiais
Pesquisador / November, 2018 — March, 2020
Universidade Federal de São Paulo Departamento de Neurologia e Neurocirurgia da UNIFESP
Full Professor / 1985 — September, 2018
Most Relevant Research Expertise
Other Research Expertise (58)
About
Most Relevant Publications (2+)
406 total publications
Sudden unexpected death in patients with epilepsy receiving renal replacement therapy with dialysis: A 17‐year experience at a single institution
Hemodialysis International / Oct 01, 2010
SCORZA, F. A., SCATTOLINI, M., CYSNEIROS, R. M., ARIDA, R. M., DE ALBUQUERQUE, M., TERRA, V. C., MACHADO, H. R., GOMES, R. A., KESROUANI, S., CRUZ, J., PELARIGO, F. C. M., SILVA, A. L., HENRIQUES, T. M. G., & CAVALHEIRO, E. A. (2010). Sudden unexpected death in patients with epilepsy receiving renal replacement therapy with dialysis: A 17‐year experience at a single institution. Hemodialysis International, 14(4), 364–369. Portico. https://doi.org/10.1111/j.1542-4758.2010.00492.x
Cardiovascular abnormalities in patients with epilepsy receiving renal replacement therapy with dialysis: a true convergence of clinical cardiology, nephrology and neurology
Nephrology Dialysis Transplantation / Feb 26, 2008
Scorza, F. A., Arida, R. M., & Cavalheiro, E. A. (2008). Cardiovascular abnormalities in patients with epilepsy receiving renal replacement therapy with dialysis: a true convergence of clinical cardiology, nephrology and neurology. Nephrology Dialysis Transplantation, 23(5), 1775–1776. https://doi.org/10.1093/ndt/gfn017
See Full Profile
Xander van Wijk, PhD, DABCC, FADLM
Strategic Leader in Clinical Diagnostics | Expert in Laboratory and Precision Medicine | Award-Winning Scientist & Author | CLIA Laboratory Director
Most Relevant Research Expertise
Other Research Expertise (40)
About
Most Relevant Publications (2+)
59 total publications
Modulation of heparan sulfate in the glomerular endothelial glycocalyx decreases leukocyte influx during experimental glomerulonephritis
Kidney International / Nov 01, 2014
LWMM Rops, A., Loeven, M. A., van Gemst, J. J., Eversen, I., Van Wijk, X. M., Dijkman, H. B., van Kuppevelt, T. H., Berden, J. H. M., Rabelink, T. J., Esko, J. D., & van der Vlag, J. (2014). Modulation of heparan sulfate in the glomerular endothelial glycocalyx decreases leukocyte influx during experimental glomerulonephritis. Kidney International, 86(5), 932–942. https://doi.org/10.1038/ki.2014.115
Large inter-assay difference of serum creatinine in pediatric population: a threat to accurate staging of chronic kidney disease
Pediatric Nephrology / Nov 10, 2021
Lao, K., Sykes, E., van Wijk, X. M. R., Li, J., Williams, J., Gherasim, C., & Sun, Q. (2021). Large inter-assay difference of serum creatinine in pediatric population: a threat to accurate staging of chronic kidney disease. Pediatric Nephrology, 37(3), 677–681. https://doi.org/10.1007/s00467-021-05335-x
See Full Profile
Mohamad Hadla
Senior Research Fellow, Mayo Clinic
Education
Università degli Studi di Padova
Ph.D., Molecular and Cellular Pharmacology / March, 2017
Università degli Studi di Pavia
M.Sc., Molecular Biology and Genetics / July, 2012
Experience
Mayo Clinic
Senior Research Fellow / July, 2022 — Present
Azienda Socio Sanitaria Territoriale Santi Paolo e Carlo
Senior Research Scientist / March, 2021 — June, 2022
Centro di Riferimento Oncologico IRCCS
Postdoctoral Researcher / January, 2017 — December, 2020
Most Relevant Research Expertise
Other Research Expertise (20)
Most Relevant Publications (1+)
17 total publications
MO409: GDF-15 is a Predictor of Mortality in Chronic Kidney Disease Patients With Covid-19 Infection
Nephrology Dialysis Transplantation / May 01, 2022
Ciceri, P., Bono, V., Magagnoli, L., Sala, M., Artioli, L., Rovito, R., Hadla, M., Yellenki, V., D’arminio Monforte, A., Galassi, A., Tincati, C., Marchetti, G., & Gennaro Cozzolino, M. (2022). MO409: GDF-15 is a Predictor of Mortality in Chronic Kidney Disease Patients With Covid-19 Infection. Nephrology Dialysis Transplantation, 37(Supplement_3). https://doi.org/10.1093/ndt/gfac070.023
See Full Profile
Anil Kumar
University of Georgia (UGA), USA
Most Relevant Research Expertise
Other Research Expertise (58)
Most Relevant Publications (1+)
89 total publications
Cloning of mouse c-ros renal cDNA, its role in development and relationship to extracellular matrix glycoproteins
Kidney International / Nov 01, 1995
Kanwar, Y. S., Liu, Z. Z., Kumar, A., Wada, J., & Carone, F. A. (1995). Cloning of mouse c-ros renal cDNA, its role in development and relationship to extracellular matrix glycoproteins. Kidney International, 48(5), 1646–1659. https://doi.org/10.1038/ki.1995.460
See Full Profile
Mehrdad Sheikhvatan
Iran University of Medical Sciences
Education
Ph.D., Medical Genetics / May, 2017
M.D., Medicine / September, 2002
Most Relevant Research Expertise
Other Research Expertise (48)
Most Relevant Publications (1+)
89 total publications
The value of N-terminal pro-B-type natriuretic peptide (NT Pro-BNP) to predict sudden cardiac death in chronic heart failure patients with normal renal function; a systematic review and meta-analysis
Journal of Nephropharmacology / Jul 27, 2018
Sheikhvatan, M., Ataei, Z., Heydari, A., & Zahergivar, A. (2018). The value of N-terminal pro-B-type natriuretic peptide (NT Pro-BNP) to predict sudden cardiac death in chronic heart failure patients with normal renal function; a systematic review and meta-analysis. Journal of Nephropharmacology, 7(2), 164–168. https://doi.org/10.15171/npj.2018.32
See Full Profile
Dr. Craig Pfeifer PhD, ATC, FHEA
Education
University of South Carolina System
PhD, Motor Behavior, Epidemiology
University of South Carolina System
MS, Athletic Training, Healthcare
Salisbury University
BS, Athletic Training, Healthcare
Most Relevant Research Expertise
Other Research Expertise (7)
Most Relevant Publications (1+)
20 total publications
Comparison of Indirect Calorimetry- and Accelerometry-Based Energy Expenditure During Children‘s Discrete Skill Performance
Research Quarterly for Exercise and Sport / Aug 23, 2019
Sacko, R., McIver, K., Brazendale, K., Pfeifer, C., Brian, A., Nesbitt, D., & Stodden, D. F. (2019). Comparison of Indirect Calorimetry- and Accelerometry-Based Energy Expenditure During Children‘s Discrete Skill Performance. Research Quarterly for Exercise and Sport, 90(4), 629–640. https://doi.org/10.1080/02701367.2019.1642440
See Full Profile
Example nephrology projects
How can companies collaborate more effectively with researchers, experts, and thought leaders to make progress on nephrology?
Drug Development for Kidney Diseases
A pharmaceutical company can collaborate with a nephrology researcher to develop new drugs for kidney diseases. The researcher's expertise in understanding the underlying mechanisms of kidney diseases and their experience in conducting clinical trials can greatly contribute to the development of effective and safe medications.
Medical Device Innovation
A medical device company can partner with a nephrology expert to innovate and improve devices used in dialysis treatments. The researcher's knowledge of dialysis procedures and patient needs can help in designing more efficient and user-friendly devices, leading to better treatment outcomes and enhanced patient experience.
Precision Medicine in Nephrology
A biotech company can collaborate with a nephrology researcher to develop personalized treatment approaches for kidney diseases. By analyzing genetic and molecular data, the researcher can identify biomarkers and genetic variants that influence disease progression and response to treatment, enabling the development of targeted therapies for individual patients.
Telemedicine Solutions for Nephrology
A healthcare technology company can work with a nephrology expert to develop telemedicine solutions for remote monitoring and management of kidney diseases. The researcher's understanding of the unique challenges faced by nephrology patients and their expertise in leveraging technology can help in creating user-friendly platforms that improve access to care and enable timely interventions.
Clinical Trials and Research Collaborations
Companies involved in clinical research can collaborate with nephrology researchers to conduct clinical trials and studies related to kidney diseases. The researcher's knowledge of disease mechanisms, patient populations, and research methodologies can contribute to the successful execution of trials, leading to the development of evidence-based treatments and therapies.